Loading viewer...
investor_presentation
Format: PDF investor_presentation
© Copyright 2018. CONVERGEONE INVESTOR PRESENTATION June 2018
CONVERGEONE INVESTOR
June 2018 © Copyright 2018. Forward Looking Statements
This presentation may include "forward -looking statements" regarding ConvergeOne with respect to its financial condition, its results of operations, its intended future capital return and its next quarterly cash dividend; and its financial outlook for
fiscal 2018. These forward -looking statements reflect ConvergeOne's current views and information currently available. This information is, where applicable, based on estimates, assumptions and analysis that ConvergeOne believes, as of the date
hereof, provide a reasonable basis for the information contained herein. Forward -looking statements can generally be identified by the use of forward -looking words such as "may", "will", "would", "could", "expect", "intend", "plan", "aim",
"estimate", "target", "anticipate", "believe", "continue", "objectives", "outlook", "guidance" or other similar words, and in clude statements regarding ConvergeOne's plans, strategies, objectives, targets and expected financial performance. These
forward -looking statements involve known and unknown risks, uncertainties and other factors, many of which are outside the contr ol of ConvergeOne . These risks, uncertainties, assumptions and other important factors include, but are not limited
to: (1) the possibility that ConvergeOne may be adversely affected by economic, business, and/or competitive factors; (2) ConvergeOne's ability to identify and integrate acquisitions and achieve expected synergies and operating efficiencies in
connection with acquired businesses; (3) changes in applicable laws or regulations; and (4) other risks and uncertainties ind icated from time to time in the reports ConvergeOne files with the Securities and Exchange Commission (“SEC”) as well as
those under "Risk Factors" included in our Quarterly Report on Form 10 -Q for the three months ended March 31, 2018, filed by ConvergeOne with the SEC. Actual results, performance or achievements may differ materially, and potentially
adversely, from any projections and forward -looking statements and the assumptions on which those vary from forward -looking stat ements are based. There can be no assurance that the data contained herein is reflective of future performance to
any degree. You are cautioned not to place undue reliance on forward -looking statements as a predictor of future performance as projected financial information, cost savings, synergies and other information are based on estimates and
assumptions that are inherently subject to various significant risks, uncertainties and other factors, many of which are beyo nd our control. All information herein speaks only as of the date hereof, in the case of information about ConvergeOne , or
the date of such information, in the case of information from persons other than ConvergeOne . Except as required under applicable law, ConvergeOne undertakes no duty to update or revise the information contained herein.
Preview truncated — download the full document for the complete content.
brochure
investor_presentation
20 Pages
Pfizer